Our extracellular matrix-based approach quantifies disease activity with precision unmatched by omics providers. The Nordic ProteinFingerPrint Technology™ offers mechanistic and pharmacodynamic insights into tissue remodeling, a process crucial to understand when evaluating the effect of a therapeutic intervention.
Accelerate your pipeline with Nordic ProteinFingerPrint Technology™ biomarkers
Nordic Bioscience’s extracellular matrix-derived biomarkers and CAP/CLIA-accredited laboratory services transform chronic disease research. We enable precision medicine and treatment insights from a simple blood sample.